Zerviate (cetirizine) NDC 82667-015

NDC codes

FDA NDC Directory

Product NDC (as listed)82667-015Labeler and product segments. Claims need a package NDC.

Product NDC at billing width82667-0015Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
82667-015-24	82667001524	1 POUCH in 1 CARTON (82667-015-24) / 30 VIAL, SINGLE-USE in 1 POUCH / 2.5 mL in 1 VIAL, SINGLE-USEMarketed from Dec 31, 2025

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Zerviate
Generic name (nonproprietary): cetirizine
Active ingredients: Cetirizine — 2.4 mg/mL
Dosage form: For solution
Route: Ophthalmic
Labeler: Harrow Eye, LLC
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 208694
Marketing start: Apr 30, 2025
Listing expires: Dec 31, 2027
Other FDA classes: Histamine H1 Receptor Antagonists (Mechanism)
Identifiers: Product ID 82667-015_5828ae2e-81de-a88b-e063-6294a90a24b3SPL ID 5828ae2e-81de-a88b-e063-6294a90a24b3SPL set ID 6fc5ef4e-4aea-4c34-8d51-0c07ab9aad59RxCUI 2119476, 2119481UNII YO7261ME24
Pharmacologic class: Histamine-1 Receptor Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Ophthalmic products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N482667001524 followed by a unit qualifier and the quantity

Package 82667-0015-24. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 3, 2026.

Indications (excerpt from the label)

ZERVIATE ® (cetirizine ophthalmic solution) 0.24% is indicated for the treatment of ocular itching associated with allergic conjunctivitis. ZERVIATE ® (cetirizine ophthalmic solution) 0.24% is a histamine-1 (H1) receptor antagonist indicated for treatment of ocular itching associated with allergic conjunctivitis. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)